Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Assets Average: 2011-2021

Historic Assets Average for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to $2.0 billion.

  • Neurocrine Biosciences' Assets Average rose 31.66% to $2.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 billion, marking a year-over-year increase of 31.66%. This contributed to the annual value of $1.5 billion for FY2020, which is 32.25% up from last year.
  • Neurocrine Biosciences' Assets Average amounted to $2.0 billion in Q3 2021, which was up 4.49% from $1.9 billion recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Assets Average peaked at $2.0 billion during Q3 2021, and registered a low of $327.2 million during Q1 2017.
  • Moreover, its 3-year median value for Assets Average was $1.4 billion (2020), whereas its average is $1.4 billion.
  • Per our database at Business Quant, Neurocrine Biosciences' Assets Average declined by 29.94% in 2017 and then skyrocketed by 148.14% in 2018.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Assets Average stood at $795.0 million in 2017, then grew by 21.18% to $963.4 million in 2018, then climbed by 29.01% to $1.2 billion in 2019, then spiked by 30.22% to $1.6 billion in 2020, then surged by 31.66% to $2.0 billion in 2021.
  • Its Assets Average stands at $2.0 billion for Q3 2021, versus $1.9 billion for Q2 2021 and $1.8 billion for Q1 2021.